Premium
Effective clinical trials investigators and adequate incentives
Author(s) -
Stamler Jeremiah
Publication year - 1979
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1002/cpt1979255part2666
Subject(s) - incentive , clinical trial , variety (cybernetics) , promotion (chess) , medical research , medical education , order (exchange) , alternative medicine , work (physics) , medicine , public relations , psychology , business , political science , computer science , law , finance , engineering , pathology , economics , mechanical engineering , artificial intelligence , politics , microeconomics
Because of the importance of randamired controlled trials in medical research and development, the most competent and qualified individuals from a variety of medical specialties are needed as investigators for these trials. Such people must be highly dedicated to the improvement of human health and they must also be cooperative and able to work in the highly disciplined atmosphere that such a trial demands. In order that the trial investigators be persons of high caliber, certain incentives must be guaranteed, such as recognition of one's contributions to the trial itself, publications, and opportunities to present study results at various meetings. University and medical school policies on promotion and tenure need to be reassessed bearing in mind the complexity of achieving optimal recognition of the individual investigator's contributions to a clinical trial.